Theophylline induces apoptosis of the IL-3 activated eosinophils of patients with bronchial asthma

Apoptosis

Volumn 4, Issue 6, 1999, Pages 461-468

  Takeuchi, M ^a   Hayakawa, A ^d   Takagi, Kenzo ^c   Hiramatsu, K ^a   Shimizu, Y ^a   Matsumoto, S ^b   Hiramatsu, T ^b   Ito, Y ^a   Kume, H ^a   Suzuki, R ^d   Yamaki, K ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Komaki Municipal Hospital   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d NONE

Author keywords

Apoptosis; Caspase 3; Eosinophil; Interleukin 3; Poly(ADP ribose) polymerase; Theophylline

Indexed keywords

CASPASE 3; DNA FRAGMENT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; THEOPHYLLINE;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTHMA; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; EOSINOPHIL; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LEUKOCYTE ACTIVATION; NUCLEOSOME; PRIORITY JOURNAL;

EID: 0032806402     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009656527168     Document Type: Article

References (32)

1. Barnes PJ. New aspects of asthma. J Intern Med 1992; 231: 451-461.
2. Busse WW, Nagata M, Sedgwick JB. Characteristics of airway eosinophils. Eur Respir J 1996; 9 (Suppl 2): 132S-135S.
3. Resnick MB, Weller PF. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 1993; 8: 349-355.
4. Morland CM, Wilson SJ, Holgate ST, Roche WR. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. Am J Respir Cell Mol Biol 1992; 6: 557-566.
5. Rothenberg ME, Owen WF, Silberstein DS, et al. Human eosinophils have prolonged survival, enhanced functional properties and become hypodense when exposed to human interleukin 3. J Clin Invest 1988; 81: 1986-1992.
6. Rothenberg ME, Petersen J, Stevens RL, et al. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype used 3T3 fibroblasts for enhanced viability, accelerated hypodensity and sustained antibody-dependent cytotoxity. J Immunol 1989; 143: 2311-2316.
7. Owen WF, Rothenberg ME, Silberstein DS, et al. Regulation of human eosinophil viability, density and function by granulocyte/macrophage colony stimulating factor in the presence of 3T3 fibroblasts. J Exp Med 1987; 166: 129-141.
8. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997; 337: 1405.
9. Markham A, Faulds D. Theophylline. A review of its potential steroid sparing effects in asthma. Drugs 1998; 56: 1081-1091.
10. Ohta K, Sawamoto S, Nakajima M, et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 1996; 26 (Suppl 2): 10-15.
11. Kerr JFR, Wyllie AH, Currie AR. Apoptosis. A basic biological phenomenon with wide-ranging implication in tissue kinetics. Br J Cancer 1972; 26: 239-257.
12. Lazebnik YA, Kaufman SH, Desnoyers S, et al. Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994, 371: 346-347.
13. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-46.
14. Tanuma S, Shiokawa D. Multiple forms of nuclear deoxyribonuclease in rat thymocytes. Biochem Biophys Res Commun 1994; 203(2): 789-797.
15. Shiokawa D, Iwamatsu A, Tanuma S. Purification, characterization, and amino acid sequencing of DNase γ from rat spleen. Arch Biochem Biophys 1997; 346: 15-20.
16. Inohara N, Koseki T, Chen S, Benedict MA, Nunez G. Identication of regulatory and catalytic domains in the apoptosis nuclease DFF40/CAD. J Biol Chem 1999; 274: 270-274.
17. Zapata JM, Takahashi R, Salvesen GS, et al. Granzyme release and caspase activation in activated human T-lymphocytes. J Biol Chem 1998; 273: 6916-6920.
18. Gleich GJ. The eosinophil and bronchial asthma. Current understanding. J Allergy Clin Immunol 1990; 85: 422-436.
19. Park CS, Choi YS, Ki SY, et al. Granulocyte macrophage colony-stimulating factor is the main cytokine enhancing survival of eosinophils in asthmatic airways. Eur Respir J 1998; 12: 872-878.
20. Walsh GM. Mechanisms of human eosinophil survival and apoptosis. Clin Exp Allergy 1997; 27: 482-487.
21. Werner L, Alexander O, Eva D, et al. Differential regulation of CD 95 (Fas/APO-1) expression in human blood eosinophils. Eur J Inmmunol 1998; 28: 2057-2065.
22. Anne D, Zhenzi C, Solomon H, Salem C, Marina P. Fasmediated apoptosis in cultured human eosinophils. Blood 1996; 87: 2822-2830.
23. Matsumoto K, Robert PS, Saito H, Iikura Y, Bruce SB. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995; 86: 1437-1443.
24. Lam A, Newhouse MT. Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? Chest 1990; 98: 44-52.
25. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderatelly severe asthma in children. Pediatrics 1993; 92: 64-77.
26. Yasui K, Bin H, Nakazawa T, Agematsu K, Kamiyama A. Theophylline accelerates human granulocyte apoptosis not via phosphodiesterase inhibitor. J Clin Invest 1997; 100: 1677-1684.
27. Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Inmmunomodulation by theophylline in asthma; demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151: 1907-1914.
28. Djukanovic R, Finnerty JP, Lee C, Wilson S, Madden J, Holgate ST. The effects of theophylline on mucosal inflammation in asthmatic airways biopsy results. Eur Respir J 1995; 8: 831-833.
29. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994; 343: 1006-1008.
30. Adachi T, Rafeul A. The mechanism of IL-5 signal transduction. Am J Physiol 1998; 275: C623-C633.
31. Hirata H, Takahashi A, Kobayashi S, et al. Caspases are activated in a braunched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med 1998; 187: 587-600.
32. Ohta T, Kinoshita T, Naito M, et al. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J Biol Chem 1997; 272: 23111-23116.